Originally established in 2011, as the Transgenics TCD facility at Trinity College Dublin, by Professor Vincent Kelly, as an enabling resource for the higher education sector. Our ever-increasing knowledge of the DNA code and basic-research discoveries in human health, disease and therapeutics meant genetically altered models of disease needed more and more to translate these discoveries into real treatments. Transgenic technologies became a requirement for cutting edge biomedical research. Since then, the facility has expanded its offerings in pre-clinical research services and carried out hundreds of projects for clients from Academia and Industry. In 2025, we opened Airmeith Bioscience to break new ground in therapeutic development in Ireland and to service this new age in drug discovery encompassing small molecules, biologics and living therapies.